Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
Life Sciences
|
February 17, 1995
Combined response of plasma and platelet catecholamines to different types of short-term stress
F Blandini, E Martignoni, E Sances, et al.
Experimental Neurology
|
May 18, 2004
Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease
F Blandini, M T Armentero, R Fancellu, et al.
Functional Neurology
|
February 24, 2001
Effect of nitric oxide donors on the central nervous system--nitroglycerin studies in the rat
C Tassorelli, A Costa, F Blandini, et al.
Experimental Neurology
|
May 30, 2008
Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease
M T Armentero, G Levandis, P Bramanti, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
October 12, 1999
Determination of hydroxyl free radical formation in human platelets using high-performance liquid chromatography with electrochemical detection
F Blandini, E Martignoni, R Ricotti, et al.
Journal of the Neurological Sciences
|
March 6, 2007
Homocysteine and Parkinson's disease: a dangerous liaison?
E Martignoni, C Tassorelli, G Nappi, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section
|
January 1, 1992
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type
E Martignoni, F Blandini, F Petraglia, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
December 9, 1997
Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection
F Blandini, E Martignoni, C Pacchetti, et al.
Clinical Neuropharmacology
|
August 1, 1991
Cardiopressor effects of short-term treatment with cabergoline in L-dopa stable responder parkinsonian patients: relevance of postprandial hypotension
A Cavallini, G Micieli, E Martignoni, et al.
Cell Death and Differentiation
|
January 10, 2004
Neurodegeneration and energy metabolism: from chemistry to clinics
F Blandini, K H Braunewell, D Manahan-Vaughan, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
Life Sciences
|
February 17, 1995
Combined response of plasma and platelet catecholamines to different types of short-term stress
F Blandini, E Martignoni, E Sances, et al.
Experimental Neurology
|
May 18, 2004
Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease
F Blandini, M T Armentero, R Fancellu, et al.
Functional Neurology
|
February 24, 2001
Effect of nitric oxide donors on the central nervous system--nitroglycerin studies in the rat
C Tassorelli, A Costa, F Blandini, et al.
Experimental Neurology
|
May 30, 2008
Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease
M T Armentero, G Levandis, P Bramanti, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
October 12, 1999
Determination of hydroxyl free radical formation in human platelets using high-performance liquid chromatography with electrochemical detection
F Blandini, E Martignoni, R Ricotti, et al.
Journal of the Neurological Sciences
|
March 6, 2007
Homocysteine and Parkinson's disease: a dangerous liaison?
E Martignoni, C Tassorelli, G Nappi, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section
|
January 1, 1992
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type
E Martignoni, F Blandini, F Petraglia, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
December 9, 1997
Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection
F Blandini, E Martignoni, C Pacchetti, et al.
Clinical Neuropharmacology
|
August 1, 1991
Cardiopressor effects of short-term treatment with cabergoline in L-dopa stable responder parkinsonian patients: relevance of postprandial hypotension
A Cavallini, G Micieli, E Martignoni, et al.
Cell Death and Differentiation
|
January 10, 2004
Neurodegeneration and energy metabolism: from chemistry to clinics
F Blandini, K H Braunewell, D Manahan-Vaughan, et al.
Page
of 6